lorazepam has been researched along with flupirtine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Borbe, HO; Nickel, B; Szelenyi, I | 1 |
Bigelow, GE; Funderburk, FR; Liebson, IA; Preston, KL | 1 |
1 trial(s) available for lorazepam and flupirtine
Article | Year |
---|---|
Evaluation of the abuse potential of the novel analgesic flupirtine maleate.
Topics: Adult; Affect; Aminopyridines; Analgesics; Arousal; Attention; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lorazepam; Male; Neuropsychological Tests; Psychomotor Performance; Substance-Related Disorders | 1991 |
5 other study(ies) available for lorazepam and flupirtine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Investigations with the novel non-opioid analgesic flupirtine in regard to possible benzodiazepine-like abuse inducing potential.
Topics: Aminopyridines; Analgesics; Animals; Anti-Anxiety Agents; Binding, Competitive; Body Weight; Brain Chemistry; Conditioning, Operant; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Female; Lorazepam; Male; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptors, GABA-A; Reinforcement Schedule; Substance-Related Disorders | 1990 |